Beam Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,892
Closed -$550K 110
2025
Q2
$550K Sell
11,892
-273
-2% -$13.4K 0.16% 89
2025
Q1
$742K Sell
12,165
-800
-6% -$46.6K 0.25% 77
2024
Q4
$733K Sell
12,965
-1,369
-10% -$76.5K 0.23% 80
2024
Q3
$742K Buy
14,334
+599
+4% +$28.1K 0.22% 77
2024
Q2
$570K Buy
+13,735
New +$615K 0.19% 82

Other funds holding BMY

Beam Wealth Advisors's BMY Position: Q3 2025 in Review

Beam Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 11,892 shares — an estimated $550K sold.

Beam Wealth Advisors first reported a position in BMY in Q2 2024 and held it in 5 quarters. The position peaked at $742K in Q1 2025. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Beam Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Beam Wealth Advisors sold 11,892 Bristol-Myers Squibb shares in Q3 2025, an estimated $550K.
  • Beam Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 5 quarters.
  • Beam Wealth Advisors's Bristol-Myers Squibb position peaked at $742K in Q1 2025.
  • 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Beam Wealth Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.